Monday, April 26, 2010

Merck suffers less than rivals on health reform

Merck suffers less than rivals on health reform

FiercePharma - 18 minutes ago

There's one Big Pharma that's not losing much to healthcare reform, relatively speaking. Merck (NYSE: MRK) says higher Medicaid rebates will cost it $170 million this year, and next year's tab ...


http://digg.com/u1UU77

No comments:

Post a Comment